Items in FPM with MESH term: Influenza, Human

Pages: Previous 1 2 3 4

Advisory Committee on Immunization Practices Issues Recommendations for the 1999-2000 Influenza Season - Special Medical Reports

Lowering the Age for Routine Influenza Vaccination to 50 Years: AAFP Leads the Nation in Influenza Vaccine Policy - Article

ABSTRACT: The American Academy of Family Physicians now recommends that all persons 50 years of age and older receive an annual influenza vaccination, because the rates of morbidity and mortality associated with influenza are high and vaccination is cost-effective. Reasons for lowering the recommended age for routine vaccination from 65 to 50 years of age include reductions in office visits, hospitalizations, time taken off work and associated costs. In working adults 18 to 64 years of age, the cost savings were estimated at $46.85 per person vaccinated. Furthermore, the fatality rate from influenza begins to rise at age 45 and is highest in persons with multiple chronic medical conditions. As in the past, recommendations target persons at high risk for complications, such as those with cardiac disease, lung disease and diabetes, as well as health care workers and residents of nursing homes. Severe allergy to eggs is a contraindication to influenza vaccination.

Influenza Vaccine for Adults 50 to 64 Years of Age - Editorials

Significant FDA Approvals in 1999 - FDA Perspective

Adult Immunization-Influenza Vaccine - Putting Prevention into Practice

ACIP Issues Recommendations for the 2000-2001 Influenza Season - Practice Guidelines

Are Neuraminidase Inhibitors Effective for Preventing and Treating Influenza in Healthy Adults and Children? - Cochrane for Clinicians

Pages: Previous 1 2 3 4


Information From Industry